Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-α-methylphenethylamine
(S)-α-methylbenzeneethanamine
Dexamfetamina
(+)-(S)-amphetamine
(S)-(+)-amphetamine
(+)-α-methylphenylethylamine
Dexamfetaminum
(S)-(+)-β-phenylisopropylamine
Desamfetamina
Dextroamphetamine adipate
Dexamfetamine
Dexamphetamine
Dexanfetamina
(+)-amphetamine
Dextroamphetamine sulfate
Dextroamphetamine saccharate
(S)-amphetamine
d-amphetamine
(S)-1-phenyl-2-aminopropane
(αS)-α-methylbenzeneethanamine
(S)-1-phenyl-2-propylamine
Dextroamphetamine
Brand Names
Dextrostat
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682